Kenji M Fujihara Selected Research

Carbon

1/2021

The TIM22 complex mediates the import of sideroflexins and is required for efficient mitochondrial one-carbon metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji M Fujihara Research Topics

Disease

7	Neoplasms (Cancer) 03/2023 - 01/2020
3	Esophageal Neoplasms (Esophageal Cancer) 03/2023 - 10/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2022 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Adenocarcinoma 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Cataract and cardiomyopathy 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019

Drug/Important Bio-Agent (IBA)

5	eprenetapoptIBA 09/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2019
2	Serine (L-Serine)FDA Link 09/2022 - 01/2021
2	Asparaginase (Elspar)FDA Link 08/2022 - 01/2021
1	Glutathione (Reduced Glutathione)IBA 09/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2022
1	EnzymesIBA 09/2022
1	Circulating Tumor DNAIBA 01/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 10/2021
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	CarbonIBA 01/2021
1	multidrug resistance-associated protein 1IBA 01/2021
1	AsparagineIBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2021
2	Neoadjuvant Therapy 03/2023 - 03/2023
1	Drug Therapy (Chemotherapy) 10/2021